R6890
R6890, sometimes known as spirochlorphine, is an orphine opioid analgesic and a member of the spiropiperidine family of agents.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
R6890, sometimes known as spirochlorphine, is an orphine opioid analgesic and a member of the spiropiperidine family of agents. The first known mention of this compound was in 1977. Other examples of agents from this class are Ro64-6198 and Ro65-6570.
Brorphine also has a similar structure. It has been sold as a designer drug, and was proposed for placement on the Schedule 1 list in the USA on 1 July 2026.
A precursor chemical used in the synthesis of R6890 is 1-phenyl-1,3,8-triazaspiro(4,5)decan-4-one (also known as spirodecanone), which is used in the synthesis of other drugs including spirilene, fluspirilene, spiramide, spiperone, RP-23618, spiroxatrine, L008716 and R5260.
See also
Cychlorphine R6372 List of orphine opioids
Text derived from https://en.wikipedia.org/w/index.php?oldid=1377263078 under CC BY-SA 4.0; modifications have been made.